| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0056 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |